Thu, Jul 16, 2020
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Biotech VC Cowen Healthcare Investments raises $493m fund

Thursday, May 21, 2020

Laxman Pai, Opalesque Asia:

Cowen Healthcare Investments (CHI) has raised $493m for its third flagship investment vehicle, beating its initial $400m target.

The private healthcare investment strategy within the investment management division of Cowen Inc said in a press release that it received commitments from existing and new investors, including institutional investors, family offices, and high net worth individuals.

The fund closure positions Cowen to continue following an investment strategy that has seen it invest in biotechs such as Akouos, AM-Pharma, and Keros Therapeutics in recent months.

Over the past eight years, Cowen has backed 38 private healthcare companies from its two previous funds. While the funds invest across biopharma, diagnostics, and digital health, drug developers have been a significant area of focus for the Cowen investment team led by Kevin Raidy, Tim Anderson and Robert Sine.

Led by Kevin Raidy, Tim Anderson, and Robert Sine, CHI was founded in 2012 to support innovation in the healthcare sector, with a particular focus on biopharma, diagnostics and digital health.

Kevin Raidy, Managing Partner, CHI, said, "Investing in premier life sciences companies could not be more critical than it is today. We are extremely optimistic about the prospects of this industry to address urgent, unmet medical needs, and in doing so to transform the lives of patients and their families. We feel privileged to be able to partner with exceptional ma......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Satori Capital buys into hedge fund manager Mountain Cove Capital Management[more]

    Laxman Pai, Opalesque Asia: Dallas-based alternatives manager founded on the principles of conscious capitalism, Satori Capital has agreed to back compatriot investment firm Mountain Cove Capital Management. Satori, a multi-strategy firm with more than $1 billion in assets under management, co

  2. SEC proposes to amend Form 13F[more]

    B. G., Opalesque Geneva: The Securities and Exchange Commission (SEC) said on Friday that it had proposed to amend Form 13F - for the first time in more than 40 years. The proposal will update the reporting threshold (currently at $100m) for institutional investment managers and make other change

  3. News Briefs: An amateur investor turned $15,000 into $1m then lost it all, the latest cautionary tale in the day-trading frenzy, SoftBank-Backed Beike Zhaofang Aims to Raise $3bn in U.S. IPO[more]

    An amateur investor turned $15,000 into $1m then lost it all, the latest cautionary tale in the day-trading frenzy From Business Insider: Robinhood-user Richard Dobatse said he turned $15,000 into $1 million, and then lost everything. He told the New York Times: "They make it so easy fo

  4. PE/VC: Could this new metric upend private equity compensation?, Venture funding remains elusive for Black tech entrepreneurs in the US, Fintech to drive biggest VC exits over next five years, Second-quarter VC investing totals appear lackluster[more]

    Could this new metric upend private equity compensation? From Institutional Investor: A secondaries investor and public pension fund are publishing what they say is the first methodology for calculating the dollar value of excess returns generated by private market investments. The

  5. Activists: Effissimo tells Toshiba that shareholders make good directors, Japan activist calls in SPV cavalry for small-cap attacks[more]

    Effissimo tells Toshiba that shareholders make good directors From Reuters: Effissimo Capital Management, which wants to install three directors on Toshiba Corp's board, told the Japanese conglomerate's directors that shareholders make good board members because they are invested in the